Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00616278 · ClinicalTrials.gov registry record
National Cooperative Growth Study in CKD
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 27
- Enrollment target
NCT00616278: Completed study, sponsored by University of California, Davis.
NCT00616278 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00616278 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether growth hormone being administered to children with Chronic Kidney Disease is effective and if it has any side effects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2005-10 |
| Est. Completion | 2010-02 |
What the finished NCT00616278 record still lists
NCT00616278 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00616278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00616278 about?
NCT00616278 is a clinical study titled "National Cooperative Growth Study in CKD". The purpose of this study is to learn whether growth hormone being administered to children with Chronic Kidney Disease is effective and if it has any side effects.
What is the current status of trial NCT00616278?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2005-10. Estimated completion is 2010-02.
Who is sponsoring clinical trial NCT00616278?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia